StockData
Bausch Health Companies Inc. logo

Bausch Health Companies Inc. (BHC) stock

BHCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3076% below fair value
$8.47+0.05 (+0.59%)

Close on Nov 17, 2026Market cap $3.17BP/E –Yield –

Bausch Health Companies pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Bausch Health Companies's pe ratio was 13.6× on Apr 30, 2026, against 54.2× a year earlier. Over the last 5 years it ranged from 2.3× to 736.9×, with a median of 51.0×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 202613.6×+6.5
2025Dec 31, 20257.2×−3.8
2023Jan 31, 202311.0×+2.0
2022Dec 30, 20229.0×+6.3
2018Apr 30, 20182.6×−2.7
2017Dec 29, 20175.3×−45.6
2016Jan 29, 201651.0×−6.5
2015Dec 31, 201557.4×−41.3
2014Dec 31, 201498.7×−638.2
2013Jan 31, 2013736.9×+72.8
2012Dec 31, 2012664.1×+451.9
2011Dec 30, 2011212.2×+185.5
2010Jan 29, 201026.8×+1.3
2009Dec 31, 200925.4×–

More Bausch Health Companies figures

See a number that looks wrong?